Search
Search Results
##search.searchResults.foundPlural##
-
-
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1323PDF: 454HTML: 158 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3207PDF: 928HTML: 2937 -
Antimicrobial Stewardship in a world racked by conflict and uncertainty: A Call for global resilience AMS in conflict areas
300PDF: 143Html: 37 -
Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19
3001PDF: 1867HTML: 962 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4051PDF: 1923HTML: 1754 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
755PDF: 486HTML: 75 -
A MULTICENTER ICET-A STUDY ON AGE AT MENARCHE AND MENSTRUAL CYCLES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) WHO STARTED EARLY CHELATION THERAPY WITH DIFFERENT CHELATING AGENTS. Age at menarche and menstrual cycles in patients with transfusion-dependent thalassemia.
749PDF: 489HTML: 102 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1355PDF: 875HTML: 1797 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4256PDF: 1361HTML: 2030 -
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5240PDF: 2619HTML: 49558 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
106PDF: 117Suppl. Files: 23HTML: 12 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1335PDF: 894Suppl. Files: 450HTML: 224 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2748PDF: 1791HTML: 3655Pellagatti Fig 1: 207Pellagatti Fig. 2: 202 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
973PDF: 977Suppl. Files: 627HTML: 115 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2035PDF: 597Suppl. Files: 280HTML: 158 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1270HTML: 294PDF: 922Suppl. Files: 440 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1166PDF: 487HTML: 208 -
-
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1590PDF: 1082HTML: 109







